---
title: CDMO Daily News — November 21, 2026
slug: daily-news-2026-11-21-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: November 21 CDMO daily: South Korea's New CDMO Special Act Enhances Biologics Manufacturing Capacity — LOTTE Biologics' early completion of its Songdo…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-11-21-cdmo
published_at: 2026-11-21T00:00:39.947Z
last_updated: 2026-11-21T00:03:35.962Z
---

### South Korea's New CDMO Special Act Enhances Biologics Manufacturing Capacity
- The Korea CDMO Special Act, effective 31 December 2026, streamlines licensing and GMP certification for biologics manufacturers.
- [LOTTE Biologics](/companies/lotte-biologics) has completed its 120,000-liter Songdo Plant 1 six months ahead of schedule, enhancing local capacity.

**Operational Impact**

[LOTTE Biologics](/companies/lotte-biologics)' early completion of its Songdo facility adds significant capacity, supporting the growing demand for biologics manufacturing in Korea.

*Source: [PharmaSource RSS](https://pharmasource.global/content/regulation/korea-cdmo-special-act-explained)*

## References

1. [PharmaSource RSS — South Korea's New CDMO Special Act Enhances Biologics Manufacturing Capacity](https://pharmasource.global/content/regulation/korea-cdmo-special-act-explained)

Source: https://www.cdmo.directory/posts/daily-news-2026-11-21-cdmo